Bumper Offer - Urjas oil Just @ Rs. 1 X
Cefactin 500 Mg Tablet is a prescription medicine that is available as a Tablet. Other than this, Cefactin 500 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Cefactin 500 Mg Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Cefactin 500 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Cefactin 500 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Cefactin 500 Mg Tablet's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Cefactin 500 Mg Tablet related warnings talks about Cefactin 500 Mg Tablet's effects on the liver, heart and kidney.
Some other conditions that can be affected by Cefactin 500 Mg Tablet are listed in the contraindications section below.
Drug reaction of Cefactin 500 Mg Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Cefactin 500 Mg Tablet is not safe while driving, and is not addiction.
Cefactin 500 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Male) |
|
| Geriatric |
|
| Adult(Female) |
|
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Cefactin 500 Mg Tablet is used -
Is the use of Cefactin 500 Mg Tablet safe for pregnant women?
Cefactin is safe for pregnant women.
Is the use of Cefactin 500 Mg Tablet safe during breastfeeding?
Cefactin does not show any side effects in breastfeeding women.
What is the effect of Cefactin 500 Mg Tablet on the Kidneys?
Cefactin rarely affects the kidneys.
What is the effect of Cefactin 500 Mg Tablet on the Liver?
Cefactin is completely safe for the liver.
What is the effect of Cefactin 500 Mg Tablet on the Heart?
You can take Cefactin without any fear of damage to the heart.
Cefactin 500 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
If you are suffering from any of the following diseases, you should not take Cefactin 500 Mg Tablet unless your doctor advises you to do so -
Is this Cefactin 500 Mg Tablet habit forming or addictive?
Cefactin 500 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Cefactin 500 Mg Tablet can make you feel drowsy.
Is it safe?
Cefactin 500 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Cefactin 500 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Cefactin 500 Mg Tablet
Taking Cefactin 500 Mg Tablet with food does not cause any problems.
Interaction between Alcohol and Cefactin 500 Mg Tablet
It is difficult to say anything about the effect of Cefactin 500 Mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftin (cefuroxime axetil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 302-312